Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-26

Clinical Trial Update: Deferoxamine for the Prevention of Cardiac Surgery-Associated Acute Kidney Injury [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating deferoxamine to prevent cardiac surgery-associated acute kidney injury; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Deferoxamine (deferoxamine)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Acute Kidney Injury | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-01-26